AI and Autonomy BioMark earns peer-reviewed validation for AI-driven lung cancer detection model BioMark’s accepted paper describes a predictive model built on metabolomic pathway data rather than single biomarkers Joseph Morton22 hours ago
AI and Autonomy Illumina partners with pharma giants to map disease biology at unprecedented scale Those models should help Merck develop virtual cell systems that better predict which diseases drugs may treat Joseph MortonJanuary 15, 2026
Medical and Pharmaceutical Researchers replicate natural immune signaling to improve cancer immunotherapy The work came from scientists at the University of Southampton’s Centre for Cancer Immunology Joseph MortonJanuary 13, 2026
Medical and Pharmaceutical Lung Cancer Research Foundation expands 2025 grant program The partnership reflects a shared focus on improving survival by catching disease earlier Joseph MortonJanuary 6, 2026
Bitcoin The year 2025 in review: A Mugglehead roundup Innovation created new avenues for wealth creation, but also exposed structural weaknesses and human error Joseph MortonDecember 30, 2025
AI and Autonomy The trajectory of artificial intelligence in 2026: A Mugglehead roundup As AI moves deeper into daily life, its influence expands beyond any single product or innovation, setting the stage for broad transformation Joseph MortonDecember 24, 2025
Medical and Pharmaceutical The next front against cancer: A Mugglehead roundup The fight is far from over, and each year brings new strategies, technologies, and therapies Joseph MortonDecember 23, 2025
Medical and Pharmaceutical Robotic-assisted bronchoscopy aids early diagnosis for lung cancer patients Lung cancer kills more people than colon, breast and prostate cancers combined Joseph MortonDecember 16, 2025
Medical and Pharmaceutical Imperial College and Pancreatic Cancer UK begin 6,000 patient breath test study Pancreatic cancer remains one of the deadliest cancers in the UK Joseph MortonDecember 9, 2025
Medical and Pharmaceutical Roche collaboration to accelerate Freenome’s blood-based cancer screening The companies intend to work jointly on improving Freenome’s cell-free DNA cancer tests Joseph MortonNovember 25, 2025